Articles by Daniel Marsh
Millions of UK Adults Skip State Pension Forecast Checks
Nearly 7 million UK adults have never checked their State Pension forecast, according to HMRC research. Many may be missing out on valuable top-up opportunities.
Federal Grant Freezes Top $177B, Savings Claims Unverified
A new tracker reports $177B in disrupted federal grants, but savings remain unverified. GAO review found only 3.8% of DOGE savings substantiated, raising investor concerns.
Zelda Ocarina Remake Unbundled From Switch 2 Launch
Nintendo's Zelda Switch 2 launch excludes Ocarina of Time, turning nostalgia into an attach-rate test. Hardware sales dip forecast, software target 60M units.
GAO Puts $6.7B Price Tag on Deferred Resignation Leave
The GAO estimates $6.7B in paid leave costs for the deferred resignation program, but cannot confirm net savings. OPM projects $20B annual savings.
BBC News Live Stream Excluded from Canadian Subscription
BBC.com's U.S. subscription includes the 24-hour BBC News livestream, but Canadian subscribers miss out due to licensing. Pricing, renewal hikes, and rights explained.
Stellantis Brampton Sale Uncertain: Roshel MOU Marks First Step
Stellantis has signed a non-binding MOU with Roshel for its Brampton plant, but a sale is far from complete. Four key hurdles remain.
Cipher Mining Surges 12% on AI Data-Center Ambitions
Cipher Mining shares jumped 12% on no fresh news, as investors bet on its AI data-center pivot. The stock's valuation now rests on future lease income.
Myer's Exposure to Cue Insolvency: A Test of Concession Model Resilience
Myer's shares were unchanged as Cue Clothing entered receivership, with the impact depending on a successful sale and the concession model's resilience.
BRICS Summit Declaration: Trade Rhetoric vs. Market Reality
At the New Delhi summit, BRICS leaders criticized tariffs and sought WTO reform, but stopped short of announcing a trade pact or common currency, leaving investors with policy signals rather than concrete market changes.
Cohere's $20B Valuation Ambition Faces Private Market Scrutiny
Cohere confirms investor interest in its Series E round, reportedly targeting a $20B valuation. The gap between private and public market metrics raises questions.
Scottish Pharmacy Groups Enter Administration as Buyers Sought for 22 Stores
Scotpharm and MSLNA have entered administration, but their 22 pharmacies continue trading while BDO seeks buyers. Suppliers are being paid normally.